NZ744397A - Blacklip abalone (haliotis rubra) extract - Google Patents

Blacklip abalone (haliotis rubra) extract

Info

Publication number
NZ744397A
NZ744397A NZ744397A NZ74439717A NZ744397A NZ 744397 A NZ744397 A NZ 744397A NZ 744397 A NZ744397 A NZ 744397A NZ 74439717 A NZ74439717 A NZ 74439717A NZ 744397 A NZ744397 A NZ 744397A
Authority
NZ
New Zealand
Prior art keywords
extract
fractions
blacklip
abalone
haliotis
Prior art date
Application number
NZ744397A
Inventor
Simone Osborne
Original Assignee
Commw Scient Ind Res Org
Fisheries Res And Development Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016900175A external-priority patent/AU2016900175A0/en
Application filed by Commw Scient Ind Res Org, Fisheries Res And Development Corporation filed Critical Commw Scient Ind Res Org
Publication of NZ744397A publication Critical patent/NZ744397A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/40—Shell-fish
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/50—Molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/204—Animal extracts
    • A23V2250/2042—Marine animal, fish extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides extracts and extract fractions of blacklip abalone (Haliotis rubra) processing waste. The extract or extract fractions comprise biologically active components, such as proteins, and anionic polysaccharides, that may be selected from anti-thrombotic agents and anti-inflammatory agents. Processes for the preparation of the extract and fractions thereof are described. The preparation process comprises enzymatic digestion, centrifugation, filtration, and desalting steps. Use of the extract or fraction as an ingredient, medicament for IL-6 mediated diseases such as arthritis, inflammatory or thrombotic diseases, dietary supplement or nutraceutical is also described.
NZ744397A 2016-01-21 2017-01-20 Blacklip abalone (haliotis rubra) extract NZ744397A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2016900175A AU2016900175A0 (en) 2016-01-21 Extract and its uses
PCT/AU2017/050041 WO2017124149A1 (en) 2016-01-21 2017-01-20 Blacklip abalone (haliotis rubra) extract

Publications (1)

Publication Number Publication Date
NZ744397A true NZ744397A (en) 2024-01-26

Family

ID=59361075

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ744397A NZ744397A (en) 2016-01-21 2017-01-20 Blacklip abalone (haliotis rubra) extract

Country Status (6)

Country Link
KR (1) KR20180103129A (en)
CN (1) CN109069547A (en)
AU (1) AU2017208715B2 (en)
NZ (1) NZ744397A (en)
WO (1) WO2017124149A1 (en)
ZA (1) ZA201804847B (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102844A1 (en) * 2001-06-15 2002-12-27 Queensland Bioprocessing Technology Pty Ltd Haemocyanin from abalone and process of purification thereof
AUPR573601A0 (en) * 2001-06-15 2001-07-12 Queensland Bioprocessing Technology Pty Ltd Novel process
KR101257494B1 (en) * 2010-05-27 2013-04-26 조선대학교산학협력단 Composition for the treatment and the prevention of inflammatory diseases in immune system containing Abalone gastrointestinal digests
WO2014062607A1 (en) * 2012-10-15 2014-04-24 Commercial Marine Biology Institute, Llc Marine extract compositions and methods of use
CN103255186B (en) * 2013-04-23 2015-03-25 集美大学 Combined production method for abalone polysaccharide, lipid and protein peptide
CN104558228A (en) * 2014-12-30 2015-04-29 大连工业大学 Method for preparing sulphated polysaccharides from abalone

Also Published As

Publication number Publication date
AU2017208715A1 (en) 2018-08-02
ZA201804847B (en) 2023-12-20
KR20180103129A (en) 2018-09-18
WO2017124149A1 (en) 2017-07-27
AU2017208715B2 (en) 2023-04-06
CN109069547A (en) 2018-12-21

Similar Documents

Publication Publication Date Title
WO2018026722A8 (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
JOP20200055A1 (en) Pyrazolopyrimidinone compounds and uses thereof
PH12017501483A1 (en) Bicyclic heterocycles as fgfr4 inhibitors
PH12018502429A1 (en) Antibody molecules for cancer treatment
PH12018502634A1 (en) Topical compositions of apremilast
EP4230627A3 (en) Inhibitors of the menin-mll interaction
CL2018003582A1 (en) Compositions to modulate the expression of c9orf72 (divisional application 201702567)
MX2020014031A (en) Heterodimeric proteins and uses thereof.
MX2017013949A (en) Silk-based moisturizer compositions and methods thereof.
MX2022014533A (en) Method for selection of high m6p recombinant proteins.
MX2012006206A (en) Combination preparations comprising exosomes and corticosteroid.
MX2021003797A (en) Immunoablative therapies.
AU2017248276A1 (en) Methods of treating ocular conditions
WO2015123493A3 (en) Compositions and methods for modulatuion of immune response
EP4275759A3 (en) Quinoline derivatives as chromobox (cbx) protein inhibitors for treating cancer
WO2021100029A3 (en) Prodrugs of fulvestrant
EP3947390A4 (en) Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease
MX2020009566A (en) Compounds as modulators of tlr2 signaling.
NZ744397A (en) Blacklip abalone (haliotis rubra) extract
EP3509614A4 (en) Methods and compositions for treatment of lafora disease
WO2019036725A3 (en) Tau aggregation peptide inhibitors
WO2018084959A3 (en) Pharmaceutical quality strontium l-lactate
MX2021008507A (en) Lilrb3-binding molecules and uses therefor.
EP3551208A4 (en) Pharmaceutical composition for the prevention or treatment of alopecia comprising eremochloa ophiuroides extract or fractions thereof as an active ingredient
EP3582787A4 (en) Pharmaceutical preparation for the prevention and treatment of inflammatory and degenerative diseases